BioCentury
ARTICLE | Company News

Biogen, Berlex autoimmune/inflammation news

August 21, 2000 7:00 AM UTC

BGEN said the U.S. District Court for the District of Massachusetts issued a summary judgement that the company's Avonex beta interferon for multiple sclerosis (MS) does not infringe Berlex's McCormi...